---
title: "Spyre Therapeutics Plunges; Why Analysts Aren't Sweating"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297076229.md"
description: "On Wednesday, Spyre Therapeutics experienced a decline in its stock value due to the failure of its rheumatoid arthritis treatment in midstage trials. The impact was significant enough to raise concerns among investors and analysts. The unsuccessful testing has caused a considerable drop in the company's stock price, leading to a negative outlook on its future prospects in the market. Despite this setback, the analysts are not overly worried about the company's overall performance, suggesting that there might be potential for recovery or alternative strategies in the future."
datetime: "2026-08-26T17:35:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297076229.md)
  - [en](https://longbridge.com/en/news/297076229.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297076229.md)
generator: "portal-rs"
---

# Spyre Therapeutics Plunges; Why Analysts Aren't Sweating

On Wednesday, Spyre Therapeutics experienced a decline in its stock value due to the failure of its rheumatoid arthritis treatment in midstage trials. The impact was significant enough to raise concerns among investors and analysts. The unsuccessful testing has caused a considerable drop in the company's stock price, leading to a negative outlook on its future prospects in the market. Despite this setback, the analysts are not overly worried about the company's overall performance, suggesting that there might be potential for recovery or alternative strategies in the future.

### Related Stocks

- [SYRE.US](https://longbridge.com/en/quote/SYRE.US.md)

## Related News & Research

- [Insider Selling: Spyre Therapeutics (NASDAQ:SYRE) Insider Sells $36,000.00 in Stock](https://longbridge.com/en/news/297984230.md)
- [Spyre Therapeutics CEO Turtle Cameron disposes of 15,000 common shares worth $1.31 million](https://longbridge.com/en/news/297975740.md)
- [Top Wall Street Forecasters Revamp Campbell's Expectations Ahead Of Q4 Earnings](https://longbridge.com/en/news/297875850.md)
- [Braidwell LP Has $16.43 Million Stake in argenex SE $ARGX](https://longbridge.com/en/news/297884648.md)
- [Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072 | SYRE Stock News](https://longbridge.com/en/news/296951295.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**